Future of Painless Injections: Needle Free Injection Market Size, Developments & Segments | Top Companies are PharmaJet, Fierce Pharma, Medical International Technology.

Needle Free Injection Market Size and Forecast

Global Needle Free Injection Market is estimated to reach at a CAGR of 15% during the forecast period 2024-2031.

DataM Intelligence has published a new research report on "Needle Free Injection Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/needle-free-injection-market?rk

Recent Developments: Needle Free Injection Market:

✅ January 2026: A leading medtech innovator unveiled an advanced laser-powered needle-free injector at a global conference, featuring improved skin penetration for biologics and vaccines to reduce injection pain and sharps waste.​

✅ August 2025: NuGen Medical Devices announced advancement of its cartridge-based needle-free system into clinical trials, targeting insulin delivery with sterile integration and backflow prevention for better user safety.

✅ September 2025: Successful field trials completed for a needle-free device administering cloprostenol in cattle, matching traditional needle efficacy for luteolysis while minimizing injury risks.​

✅ July 2025: PharmaJet signed an MOU with Egyptian health authorities and EVA Pharma to roll out needle-free systems in national immunization drives, boosting access in high-volume vaccination settings.​

Mergers & Acquisitions:

✅ December 2025: Serum Institute of India acquired a 20% stake in IntegriMedical, fast-tracking needle-free tech for vaccines to cut needlestick injuries and enhance global delivery efficiency.

✅ October 2025: A major pharma distributor partnered via equity investment in a needle-free startup, expanding production for diabetes and vaccine markets amid rising demand for painless alternatives.​

✅ July 2025: ANEW Medical licensed needle-free dry powder autoinjector tech from Transfertech Sherbrooke, aiming to integrate into self-administration devices for chronic therapies.​

✅ June 2025: Regional medtech firm acquired predictive analytics tools for needle-free systems, enabling remote monitoring to lower downtime in clinical and veterinary applications.

Key Market Drivers: Needle Free Injection Market:

✅ Rising prevalence of chronic diseases like diabetes drives demand for self-injection devices, with needle-free systems offering pain-free alternatives to improve patient compliance.

✅ Needle phobia and needlestick injury risks fuel adoption, as needle-free tech eliminates sharps waste and reduces infection transmission in healthcare settings.

✅ Expanding vaccination programs, including post-COVID initiatives, boost usage for rapid, efficient mass immunization without storage challenges of traditional syringes.

✅ Technological advancements in jet and laser-based systems enhance drug bioavailability, precision, and portability, attracting pharma investments for biologics delivery.

✅ Aging populations and healthcare infrastructure growth in emerging markets like India and China increase access to user-friendly, low-cost self-administration tools.

Company Contributions: Needle Free Injection Market:

FlowBeams (BoldJet)
✅ Showcased BoldJet at CES 2025 (January 2025), using laser-induced cavitation for high-precision microfluidic jets targeting skin layers for vaccines, insulin, and cosmetics like Botox. Virtually painless, reduces needlestick injuries and 16-32 billion annual needle/syringe waste globally.​

✅ Technology enables controlled depth delivery via repetitive thin jets, minimizing pain and biowaste; supported by European Innovation Council grants for healthcare and dermatology scalability.

NuGen Medical Devices
✅ August 2025: Advanced cartridge-based needle-free system to clinical trials, integrating sterile cartridges for insulin delivery with backflow prevention and enhanced user safety.

IntegriMedical (with Serum Institute of India)
✅ December 2025: Serum acquired 20% stake to accelerate needle-free tech for vaccines/biologics, focusing on patient comfort, reduced needlestick injuries, and efficient global delivery.

PharmaJet
✅ July 2025: Signed MOU with Egyptian UPA and EVA Pharma for needle-free rollout in national immunization programs, enabling high-volume, rapid vaccinations.​

ANEW Medical
✅ Licensed dry powder autoinjector technology from Transfertech Sherbrooke (2025), integrating into self-administration devices for chronic therapies like diabetes management.

​Key Players:

Endo International, PharmaJet, Fierce Pharma, Medical International Technology, INJEX Pharma, National Medical Products, European Pharma Group, PenJet Corporation, and Crossject among others.

Growth Forecast Projected:

The Global Needle Free Injection Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Needle Free Injection Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=needle-free-injection-market?rk

Key Segments:

By Type: Liquid-based, Projectile, Powder-based.

By Site of Delivery: Intradermal injectors, Intramuscular injectors, Subcutaneous injectors.

By Application: Vaccine Delivery, Insulin Delivery, Pain Management and Others.

By End User: Hospitals, Clinics, Home Care settings, and Others.

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/needle-free-injection-market?rk

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?rk

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.